3-Bromo-5-methyl-6-nitro-1H-indazole

Catalog No.: 
ACPZWE432
CAS No.: 
1082040-69-4
Molecular Formula: 
C8H6BrN3O2
Molecular Weight: 
256.06
3-Bromo-5-methyl-6-nitro-1H-indazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$209.00In stockInquiry
250mg95%$348.00In stockInquiry
1g95%$695.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-5-methyl-6-nitro-1H-indazole
IUPAC Name3-bromo-5-methyl-6-nitro-2H-indazole
MDL No.MFCD11845491
Molecular FormulaC8H6BrN3O2
Molecular Weight256.06
SMILESO=[N+](C1=CC2=C(C=C1C)C(Br)=NN2)[O-]
InChI KeyHBYMRDKKBLIACT-UHFFFAOYSA-N
Synonym3-BroMo-5-Methyl-6-nitro (1H)indazole;3-Bromo-5-Methyl-6-Nitro (1H)Indazole(WXC01818);1H-Indazole, 3-bromo-5-methyl-6-nitro-
CAS No.1082040-69-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPZWE432 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACVACO762 route compound structure diagram
    ACVACO76272521-00-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPZWE432 route product structure diagram
    ACPZWE4321082040-69-4In Stock
Inquiry

2. ACPZWE432 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCWDA697 route compound structure diagram
    ACCWDA69713061-96-6
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPZWE432 route product structure diagram
    ACPZWE4321082040-69-4In Stock
Inquiry

3. ACPZWE432 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPZWE432 route product structure diagram
    ACPZWE4321082040-69-4In Stock
Inquiry

Comments (0)